General information

l have followed this forum for a number of years, although l have been keeping a low profile. l appreciate all the comments but l do find some of them a bit challenging in regard to an unnecessary derailing of information affecting our momentum. Prescient Therapeutics Ltd has enormous potential and in regard to PTX100 l think we will hear back from the FDA in the (near) future as l am sure our lodgment of documents for phase 2 would have been lodged by now. With our impeccable safety record and our overall results in regard to our phase 1 patients, l think it is reasonable to expect a similar response from our new selection of patients. And let's face it, profit is one thing but saving lives is immense in comparison. l would like to thank you Shellbell for your amazing effort l can't help but think that you maybe in the medical arena in some way, but put that aside your time is appreciated. It is my belief that when we move forward with the phase 2 trial there will be interest from local and global pharmaceutical companies, statistics tell me we are likely to see an elevation in the SP during phase 2. Let's not forget the potential of at least 2 of our other treatments. And l can hear someone say in the background l wonder if the person is a shareholder, l can answer that for you l am a substantial shareholder.